2.51
price down icon8.39%   -0.23
 
loading
Schlusskurs vom Vortag:
$2.74
Offen:
$2.64
24-Stunden-Volumen:
14,032
Relative Volume:
0.07
Marktkapitalisierung:
$139.81M
Einnahmen:
$18.85M
Nettoeinkommen (Verlust:
$-119.67M
KGV:
-1.2354
EPS:
-2.0318
Netto-Cashflow:
$-89.09M
1W Leistung:
-5.64%
1M Leistung:
-8.06%
6M Leistung:
-34.12%
1J Leistung:
-38.18%
1-Tages-Spanne:
Value
$2.51
$2.67
1-Wochen-Bereich:
Value
$2.51
$2.767
52-Wochen-Spanne:
Value
$1.53
$4.75

Inventiva Adr Stock (IVA) Company Profile

Name
Firmenname
Inventiva Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
123
Name
Twitter
Name
Nächster Verdiensttermin
2024-09-25
Name
Neueste SEC-Einreichungen
Name
IVA's Discussions on Twitter

Vergleichen Sie IVA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
IVA 2.51 139.81M 18.85M -119.67M -89.09M -2.0318
VRTX 450.13 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.29 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 593.52 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.66 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.58 24.89B 3.30B -501.07M 1.03B 11.54

Inventiva Adr Stock (IVA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-10-27 Eingeleitet Canaccord Genuity Buy
2023-05-31 Eingeleitet ROTH MKM Buy
2023-05-19 Hochstufung Societe Generale Sell → Buy
2023-03-17 Eingeleitet Stifel Buy
2022-11-15 Herabstufung Societe Generale Buy → Sell
2021-03-08 Herabstufung Societe Generale Buy → Sell
2020-08-05 Eingeleitet ROTH Capital Buy
2020-08-04 Eingeleitet Guggenheim Buy
2020-08-04 Eingeleitet Stifel Buy
Alle ansehen

Inventiva Adr Aktie (IVA) Neueste Nachrichten

pulisher
Nov 20, 2024

Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024 - GlobeNewswire Inc.

Nov 20, 2024
pulisher
Oct 24, 2024

Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Oct 24, 2024
pulisher
Oct 14, 2024

Inventiva ADR (IVA) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com

Oct 14, 2024
pulisher
Aug 28, 2024

Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - Inventiva

Aug 28, 2024
pulisher
Jul 08, 2024

Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketParamount ... - Benzinga

Jul 08, 2024
pulisher
Jul 05, 2024

Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and ... - GlobeNewswire Inc.

Jul 05, 2024
pulisher
Jun 18, 2024

Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Yahoo Finance

Jun 18, 2024
pulisher
May 30, 2024

Assemblée Générale Mixte du 20 juin 2024 - GlobeNewswire Inc.

May 30, 2024
pulisher
May 16, 2024

Inventiva's Key Drug Trial Advances PositivelyTipRanks.com - TipRanks

May 16, 2024
pulisher
May 14, 2024

Inventiva SA ADR Announces Key General MeetingTipRanks.com - TipRanks

May 14, 2024
pulisher
May 14, 2024

Inventiva's Lanifibranor Shows Promise in MASH/NASH TreatmentTipRanks.com - TipRanks

May 14, 2024
pulisher
Apr 04, 2024

Inventiva's Latest Move: Issuing Royalty Certificates That Could Dilute Lanifibranor EarningsTipRanks.com - TipRanks

Apr 04, 2024
pulisher
Mar 30, 2024

Will Election Commission Make Sure That Elections In 2024 Will Be Completely Fair? - Inventiva

Mar 30, 2024
pulisher
Mar 27, 2024

Inventiva SA ADR Announces Optimistic 2023 ResultsTipRanks.com - TipRanks

Mar 27, 2024
pulisher
Mar 18, 2024

Inventiva’s LEGEND Trial Shows Promising Results - TipRanks

Mar 18, 2024
pulisher
Mar 08, 2024

Is SBI's Demand For Extra Time To Disclose Details Of Electoral Bonds 1 Attempt To Hide The Doings And Doers Of ‘Great Political Chanda’? - Inventiva

Mar 08, 2024
pulisher
Feb 12, 2024

IVA Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Oct 10, 2023

Supreme Court To Hear Plea Against Electoral Bonds From October 31 - Inventiva

Oct 10, 2023
pulisher
Sep 04, 2023

National Parties Declare Assets Worth Rs 8,829 Crore In 2021-22: Report - Inventiva

Sep 04, 2023
pulisher
Jul 29, 2023

Explosive Showdown: Rahul Yadav-Led 4B Networks Clash with Info Edge in High-Stakes Arbitration Battle - Inventiva

Jul 29, 2023
pulisher
Apr 13, 2023

The Indian Chief Ministers Are A Bunch Of Crorepatis While The Average Middle-Class Indian Tax Payer Is Struggling To Survive - Inventiva

Apr 13, 2023
pulisher
Mar 06, 2023

Top 10 Best Health & Wellness Companies In USA 2023 - Inventiva

Mar 06, 2023
pulisher
Feb 22, 2023

Top 20 Best Hardware & Networking Company In India 2023 - Inventiva

Feb 22, 2023
pulisher
Nov 11, 2022

Top 10 Best Law Firms In India 2023. - Inventiva

Nov 11, 2022
pulisher
Oct 19, 2022

Top 10 Best LegalTech companies in India 2023 - Inventiva

Oct 19, 2022
pulisher
Apr 23, 2022

An Interesting Telecom Startup Announced Funding Of INR 30 Crore - Inventiva

Apr 23, 2022
pulisher
Apr 18, 2022

TCS, Infosys, Wipro Hire Over 1 Lakh Employees This Fiscal. Know Details - Inventiva

Apr 18, 2022
pulisher
Mar 05, 2022

8 US equities have commenced trading on the NSE IFSC in GIFT City; All information about how to start trading through IFSC and should you put money in US stocks? - Inventiva

Mar 05, 2022
pulisher
Feb 23, 2022

Innovation And Technology Revolutionizing The Legal Landscape In India 2022 - Inventiva

Feb 23, 2022
pulisher
Dec 24, 2021

India Has Its First Most Awaited International Arbitration Centre In Hyderabad In 2021. - Inventiva

Dec 24, 2021
pulisher
Jan 22, 2021

The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa - Yahoo Finance

Jan 22, 2021
pulisher
Jan 21, 2021

The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer I - Benzinga

Jan 21, 2021
pulisher
Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider

Jan 20, 2021
pulisher
Jul 15, 2020

The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance

Jul 15, 2020

Finanzdaten der Inventiva Adr-Aktie (IVA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):